Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1625703

This article is part of the Research TopicAdvances in Surgical Techniques and ML/DL-based Prognostic Biomarkers for Surgical and Adjuvant Therapies of Hepatobiliary and Pancreatic CancersView all 5 articles

A Multi-Algorithm Prognostic Model Combining Inflammatory Indices and Surgical Features in Distal Cholangiocarcinoma

Provisionally accepted
Yi  YinYi Yin1,2Luyuan  BaiLuyuan Bai3Xinyue  MuXinyue Mu1,2Shan  ZhangShan Zhang3Panpan  ZhaiPanpan Zhai1,2*
  • 1Pediatrics Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China
  • 2School of Pediatrics, Henan University of Chinese Medicine, Zhengzhou, China
  • 3Henan Province Hospital of Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou, China

The final, formatted version of the article will be published soon.

Background: Derived neutrophil-to-lymphocyte ratio (dNLR) is an emerging blood-based inflammatory biomarker previously reported to have prognostic value in various malignancies.This study aimed to investigate the prognostic significance of dNLR in patients with distal cholangiocarcinoma (dCCA) after curative resection.Methods: Clinicopathological data of patients with dCCA in our hospital from Jan.2014 to Jun.2024 was analyzed retrospectively. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive value of dNLR and to identify the optimal cutoff.Survival differences between groups stratified by dNLR were compared using Kaplan-Meier analysis. Candidate variables were screened through univariate analysis using Kaplan-Meier, random forest, Recursive Feature Elimination (RFE) and least absolute shrinkage and selection operator (LASSO) regression models. Multivariate Cox regression analysis identified independent prognostic factors, which were subsequently integrated into a predictive model visualized via a nomogram. Model performance was assessed using ROC curves, calibration curves, and decision curve analysis (DCA).Results: A total of 177 patients were enrolled in this study. ROC analysis revealed an area under the curve (AUC) of 0.707 for dNLR in predicting postoperative survival, with an optimal cutoff value of 1.60. Patients stratified into a low-dNLR group (≤ 1.60) demonstrated significantly improved recurrence-free survival (41 months) and overall survival (17 months) compared to those in the high-dNLR group (> 1.60) (p < 0.05). Univariate and multivariate combined with 3 machine learning analyses identified preoperative dNLR > 1.60 as an independent adverse prognostic factor for postoperative outcomes, incorporating with other independent predictors (preoperative total bilirubin, carbohydrate antigen 19-9 levels, T-stage, portal venous system invasion, and lymph node metastasis) further enhanced the predictive accuracy of the prognostic model.A preoperative dNLR > 1.60 is an independent risk factor associated with poor prognosis in patients with dCCA. The clinical prediction model based on machine learning incorporating dNLR effectively predicts postoperative outcomes in this patient population.

Keywords: machine learning, Pancreaticoduodenectomy, distal cholangiocarcinoma, Derived neutrophil-to-lymphocyte ratio (dNLR), prognosis

Received: 09 May 2025; Accepted: 30 Jun 2025.

Copyright: © 2025 Yin, Bai, Mu, Zhang and Zhai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Panpan Zhai, Pediatrics Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.